Short interest on Daxor Co. (NASDAQ:DXR) up 39.6%

Daxor Co. (NASDAQ:DXR – Get Free Report ) received a significant increase in short interest in September. As of September 15th, there was short interest totaling 14,800 shares, up 39.6% from August 31st’s total of 10,600 shares. Based on an average daily trading volume of 4,000 shares, the days-to-cover ratio is currently 3.7 days. About 0.7% of the company’s shares are short sold.

The Wall Street analyst weighs in

Separately, Ascendiant Capital Markets boosted their price objective on shares of Daxor from $24.50 to $24.75 and gave the company a “buy” rating in a report on Monday, September 9th.

Read the latest stock report on DXR

Daxor stock down 2.3%

Shares of DXR traded down $0.21 during trading on Friday, hitting $8.89. 21,291 shares of the stock traded hands, compared to its average volume of 3,723. Daxor has a 52 week low of $7.11 and a 52 week high of $10.04. The company’s fifty day moving average price is $8.90 and its 200 day moving average price is $9.08.

About Daxor

(Get a free report)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets the BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate and objective quantification of blood volume status and composition compared to patient-specific norms for use in a wide range of medical conditions and surgical.

See Also

Get news and reviews for Daxor Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Daxor and related companies with MarketBeat.com’s FREE daily email newsletter.